RNase activity of a DNA minor groove binder with a minimalist catalytic motif from RNase A.
Imidazole and compounds containing imidazole residues have been shown to cleave RNA in an RNase A-mimicking manner. Di-imidazole lexitropsin is a compound which is derived from the polyamide drugs distamycin and netropsin essentially by the replacement of two pyrrole heterocycles with N-methyl-imidazole residues. This enables it to bind to the minor groove of B-DNA in a sequence-specific manner. We demonstrate here that this lexitropsin derivative has RNA cleavage activity, as tested on model RNAs. Optimal cleavage conditions and cleavage specificity resemble those known from other imidazole conjugates and are thus consistent with an RNase A type cleavage mechanism. The optimum concentration of the compound for cleavage is similar to previously investigated imidazole-based RNase mimics. As a whole new class of chemical compounds capable of interacting with nucleic acids through extensive hydrogen bonding, these imidazole containing compounds constitute promising scaffolds and ligands, for the construction of novel RNase mimics with high affinity.
Département 'Mécanismes et Macromolécules de la Synthèse Protéique et Cristallogenèse', UPR 9002, Institut de Biologie Moléculaire et Cellulaire du CNRS, 15 rue René Descartes, Strasbourg Cedex, F 67084, France. helm@seqaxp.bio.caltech.edu
M
M
Helm
M L
ML
Kopka
S K
SK
Sharma
J W
JW
Lown
R
R
Giegé
D000818:Animals; D020134:Catalytic Domain; D004247:DNA / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D009429:Netropsin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology*; D009690:Nucleic Acid Conformation; D012343:RNA, Transfer / Q000187:drug effects* / Q000378:metabolism; D012259:Ribonuclease, Pancreatic / Q000378:metabolism*; D013379:Substrate Specificity
C108420:di-imidazole lexitropsin; D009429:Netropsin; D004247:DNA; D012343:RNA, Transfer; D012259:Ribonuclease, Pancreatic